| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $100.6M | +5.4% |
| Cost of Revenue | $107.4M | -22.5% |
| R&D Expense | $18.7M | -0.9% |
| SG&A Expense | $48.7M | +33.0% |
| Operating Income | -$126.7M | +3.2% |
| Pre-tax Income | -$81.8M | +76.0% |
| Income Tax | $67K | +103.3% |
| Net Income | -$81.8M | +75.8% |
| EPS (Basic) | -$0.32 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.9M | +108.7% |
| Accounts Receivable | $11.9M | +21.3% |
| Current Assets | $264.5M | +94.3% |
| Total Assets | $336.8M | +72.5% |
| Current Liabilities | $45.3M | -79.1% |
| Total Liabilities | $62.0M | -76.0% |
| Stockholders' Equity | $274.8M | +535.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.4M | +19.1% |
| Capital Expenditures | $4.1M | +52.1% |
| Investing Cash Flow | -$26.1M | -66.5% |
| Financing Cash Flow | $220.4M | — |
| Free Cash Flow | -$74.5M | +16.9% |
| +80.7% |
| EPS (Diluted) | -$0.32 | +80.7% |